3F
BSX icon

360 Financial’s Boston Scientific BSX Stock Holding History

360 Financial’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,824
Closed -$240K – 86
2026
Q1 		$240K Hold
3,824
– – 0.07% 69
2025
Q4 		$365K Hold
3,824
– – 0.11% 57
2025
Q3 		$373K Sell
3,824
-281
-7% -$29.1K 0.12% 58
2025
Q2 		$441K Buy
+4,105
New +$415K 0.14% 54

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

360 Financial's BSX Position: Q2 2026 in Review

360 Financial sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,824 shares — an estimated $240K sold.

360 Financial first reported a position in BSX in Q2 2025 and held it in 4 quarters. The position peaked at $441K in Q2 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • 360 Financial reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • 360 Financial sold 3,824 Boston Scientific shares in Q2 2026, an estimated $240K.
  • 360 Financial first reported a position in Boston Scientific in Q2 2025 and held it in 4 quarters.
  • 360 Financial's Boston Scientific position peaked at $441K in Q2 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on 360 Financial's 13F filing for Q2 2026, filed 11 Aug 2026.